Advanced search
Publication Cover
International Journal of Hyperthermia Volume 19, 2003 - Issue 1
Submit an article Journal homepage
171
Views
23
CrossRef citations to date
0
Altmetric
Research Article

Anaesthesiological experiences with whole body hyperthermia

T. Kerner Department of Anaesthesiology and Critical Care Medicine, Charité Medical Center, Virchow Hospital, Humboldt University, D-13344 Berlin, Germany
,
B. Hildebrandt Department of Hematology and Oncology, Charité Medical Center, Virchow Hospital, Humboldt University, D-13344 Berlin, Germany
,
O. Ahlers Department of Anaesthesiology and Critical Care Medicine, Charité Medical Center, Virchow Hospital, Humboldt University, D-13344 Berlin, Germany
,
M. Deja Department of Anaesthesiology and Critical Care Medicine, Charité Medical Center, Virchow Hospital, Humboldt University, D-13344 Berlin, Germany
,
H. Riess Department of Hematology and Oncology, Charité Medical Center, Virchow Hospital, Humboldt University, D-13344 Berlin, Germany
,
J. Draeger Department of Radiology, Charité Medical Center, Virchow Hospital, Humboldt University, D-13344 Berlin, Germany
,
P. Wust Department of Radiology, Charité Medical Center, Virchow Hospital, Humboldt University, D-13344 Berlin, Germany
&
H. Gerlach Department of Anaesthesiology and Critical Care Medicine, Charité Medical Center, Virchow Hospital, Humboldt University, D-13344 Berlin, Germany
 show all
Pages 1-12 | Published online: 09 Jul 2009

  • [Line 8]Valdagni R. Amichetti M. Report of a long-term follow-up in a randomized trial comparing radiation therapy and radiation plus hyperihermia to metastatic lymph nodes in state IV head and neck cancer patients. Int J Radiat Oncol 1993; 28: 163-9.
  • [Line 37]van der Zee J. Gonzalez Gonzales D, van Rhoon GC. can Dijk JDP. van Putten WI J. Hart AAM. Comparison of radiotherapy alone with radiotherapy plus liyperthermia in locally advanced pelvic tumors: a prospective, randomised, multicentre trial, Lancet 2000: 355: 1119-25.
  • [Line 70]Vernon CC. Hand JW. Field SB. Machin D. Whaley JB. van der Zee J. van Putten WI., van Rhoon GC. van Dijk JD. Gonzalez Gonzalez D. Liu FF. Goodman P. Sherar M. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from live randomized controlled trials. Int J Radiol Oncol Biol Phys 1996. 35: 731-44.
  • [Line 110]Overgaard J. Gonzalez-Gonzalez D. Hulshoff MC. Arcangeli G. Dahl O. Mella O. Bentzen SM. Randomised trial of hypertherma as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology. Lancet 1995; 345: 540-3.
  • [Line 144]Robins HI, Dennis WH. Neville AJ. Shecterie LM. Martin PA. GrosMium J. Davis TE. Neville SR. Gillis WK. Rusy BF. A nontoxic system for 418 C whole-body hyperthermia: results of a Phase I study using a radiant heat device. Cancer Res 1985: 45: 3937-44.
  • [Line 181]Wust P. Riess H. Hildebrandt B. LoffeI J. Deja M. Ahlers O. Kerner E, von Ardenne A. Felix R. Feasibility and analysis of thermal parameters for the whole-body-hyperthermia system IRATHERM-2000. Int J Hyperthermia 2000; 16; 325-39.
  • [Line 217]Wehner H. von Ardenne A. Kaltofen S. Whole-body hyperthermia with waterfiltered infrared radiation: technical aspects and clinical experiences. Int J. Hyperthermia 2001; 17; 19-30.
  • [Line 247]Robins HLI Cohen JD. Schmitt CL, Tutsch KD. Feterabend C. Arzoomanian RZ. Alberti D. d'Oleire F. Longo W. Fleiss C. Rushing D. Love R. Spriggs D. Phase 1 clinical trial of carboplatin and 418 C whole-body hyperthermia in cancer patients. J Clin Oncol 1993; 9: 1787-94.
  • [Line 287]Robins HI. Rushing D. Kutz M. Tutsch KD. Tiggelaar CL. Paul D. Spriggs D. Kraemer C. Gillis WK. Feierabend C. Arzoomanian RZ, Longo W. Alberti D. d'Oleirc F. Qu RP. Wilding G. Stewart JA. Phase F clinical trial of melphalan and 418 C whole-body hyperthermia in cancer patients. J. Clin Oncol 1997; 15: 158-64.
  • [Line 331]Wiedemann GJ. Katschinsky DM. Mentzel M. D'Oliere F. Wagner T. Robins HI. Ifosfamide. carboplatin and etoposide combined with aquatherm induced 418 C wholebody hyperthermia (WBH) for refractory sarcoma. J Clin Oncol 1996; 14: 1751.
  • [Line 362]Hegewisch-Becker S. Gruber Y. Panse J. Alunaekowic D, Niehaus A. Hossfeid DK. Whole-body hyperthermia (WBH 41.8 C) as an adjunct to oxtiplatin (OXA) 5-FU F A in high-dose (HD)-5-FU. FA or HD-5-FUFA and CTT-II refractory, relapsed advanced colorectal cancer. Ann Oncol 2000: 11; 67.
  • [Line 393]Rjosk D. Bergauer F. Jauni W. Strobl B. Pohl K. Buchlfelder A, Sommer H. Phase Il trial evaluating safety and efficiacy of chemotherapy with carboplatin and paelitaxel combined with extreme whole body hyperthermia in patients with ovarian cancer. Ann Oncol 2000: II (Suppl 4): 86.
  • [Line 426]Bakshandch A. Bruns I. Eiberhardt K. Demedts A. Kaukel E. Gatzemeier E. Dhalhoff K. Jäger E. Jäger D. Knuth A. Hegewisch-Becker S. Hossfeld DK. Wiedemann GJ. Hosfamide. carboplatin and eloposide combined with aquatherm-induced 41.8 C wholebody hyperthermia for adult patients with malignant pleural mesothelioma. Ann Oncol 2000: II(Suppl. 4): 113.
  • [Line 465]Kerner T. Deja M. Ahlers O. LoffeI J. Hildebrandt B, Wust P. Gerlach H. Reiss H. Whole body hyperthermia: a secure procedure for patients with various malignancies" Intensive Care Med 1999: 25: 959-65.
  • [Line 500]Stern DH. Gerson JI. Allen FB. Parker FB. Can we trust the direct radial artery pressure immediately following cardiopulmonary bypass' Anesthesiology 1985: 62: 557-61.
  • [Line 531]Pauca AL.Hudspeth AS. Wallenhaupt SL. Tucker WY, Kon ND. Mills SA. Cordell AR. Radial artery-to-anrta pressure difference after discontinuation of cardiopulmonary bypass. Anestheuology 1989: 70: 935-41.
  • [Line 565]Gravlee GP. Brauer SD. O'Rourke MF. Avolio AP. A comparison of brachial, femoral, and aortic intra-arterial pressures before and after cardiopulmonary bypass. Anaesch Intensive Care 1989: 17; 305-11.
  • [Line 596]Rich GF. Lubanski REJ. McLoughlin TM. Differences between aortic and radial artery pressure associated with cardiopulmonary bypass. Anesthesiology 1992: 77: 63-6.
  • [Line 626]Hynson JM. Sessler DI. Moayeri A. Katz JA. Thermoregulatory and anesthetic-induced alterations in the differences among femoral, radial, and oscillometric blood pressures. Anesthesiology 1994; 81: 1411-21.
  • [Line 657]Barlogic B. Corry PM. Yip E. Lippmann L. Johnston DA. Khalil K. Teuztynski TF Reilly E, Dosik G. Rigor B. Hankenson EJ. Freireich EJ. Total-body hyperthermia with and without chemotherapy for advanced human neoplasma. Cancer Res 1979: 39: 1481-9.
  • [Line 695]Herman TS. Sweets CC. White DM. Gerner EW. Effect of heating on lethality due to hyperthermia and selected chemotherapeutic drugs. J Natl Cancer Inst 1982: 68: 487-91.
  • [Line 726]Larkin JM. A clinical investigation of total body hyperthermia as cancer therapy. Cancer Res 1979: 39: 2252-4.
  • [Line 754]van der Zee J. van Rhoon G. Wike-Hoolcy JJ. I Faithful S. Reinhold US. Whole-body hyperthermia in cancer therapy, a report of a phase 1,II study. Eur J Cancer Clin Oncol 1983: 19: 1189-200.
  • [Line 786]Robins HI. Longo WI.. Lagoni RK. Neville AJ. Riggs C". Schmitt CL. Hugander A. Young C. A phase I trial of lonidamine with whole body hyperthermia in advanced cancer Cancer Res 1988: 43: 6587-92.
  • [Line 821]Steinliausen D. Mayer WR, Andenne M. Evaluation of systemic tolerance of 42.0 C Infrared-A whole-body hyperthermia in combination with hyperglycemia and hyperoxemia. A phase-I study. Strahlenther Onkol 1994: 170: 322-34.
  • [Line 851]Parks LC. Minaberry D. Smith DP. Neely WA. Treatment of far-advanced bronchogenic carcinoma by extraeorporeally induced systemic hyperthermia. J Thorac Cardiovasc Surg 1979: 78: 883-92.
  • [Line 882]Pettigrew RT, Galt JM. Ludgate CM. Horn DB. Smith AN. Circulatory and biochemical effects of whole body hyperthermia. Br J Surg 1974; 61: 727-30.
  • [Line 914]Kim YD. Lake CR. Lees DE. Schuette WH. Bull JM. Weise V. Kopin JJ. Hemodynamic and plasma catccholamine responses to hyperthermic cancer therapy in humans. Am J Physiol 1979: 237: H570-4.
  • [Line 948]Lees DE. Kim YD. Bull JM. Whang Peng J. Schuette W. Smith R. Macnamara TE. Anesthetic management of whole-body hyperthermia for the treatment of cancer. Anesthesiology 1980: 52: 418-28.
  • [Line 982]Ostrow S. Van Echo D. Whitaere M. Aisner J. Simon R. Wiernik PH. Physiologic response and toxicity in patients undergoing whole-body hyperthermia for the treatment of cancer. Cancer Treat Rep 1981; 65: 323-5.
  • [Line 1015]Faithfull NS. Reinhold HS. van den Berg AP. van Rhoon GC. van der Zee J. WikeHooley JL. Cardiovascular changes during whole body hyperthermia treatment of advanced malignancy. Eur J April Physiol 1984: 53: 274-81.
  • [Line 1048]Robins H. Hugander A. Besozzi M. Schmitt CL. Martin PA. Zager I.V. Grossman J. Beta-blockade during whole-body hyperthermia: a toxicity study in the dog. Int J Hyperthermia 1991:7: 263-70.
  • [Line 1082]Berry JM. Michalsen A. Nagle V. Bull JM. The use of esmolol in whole-body hyperthermia: cardiovascular effects. Int J Hypterthermia 1997: 13:261-8.
  • [Line 1113]Urzua J. Aortic-to-radial arterial pressure gradient after bypass. Anesthesiology 1990: 73: 191.
  • [Line 1139]Brengelmann GL. Circulatory adjustments to exercise and heat stress. Ann Rev Physiol 1983: 45: 191-212.
  • [Line 1167]Hynson JM. Kalz JA. Mangano DT. On the accuracy of intra-arterial pressure measurement: the pressure gradient effect. Crit Care Med 1998: 26: 1623-4.
  • [Line 1197]Sessler DI. Moayeri A. Stoen R. Glosten B. Hynson J. McGuire J. Thermoregulatory vasoconstriction decreases cutaneous heat loss. Anesthesiology 1990: 73: 656-60.
  • [Line 1230]Foxall PJ. Singer JM. Hartley JM. Neild GH. Lapsley M. Nicholson JK. Souhami RL. Urinary proton magnetic resonance studies of early ifosfamide-induced nephrotoxicity and encephatopathy. Clin Cancer Res 1997: 3: 1507-18.
  • [Line 1264]Brauer LP. Prieshof B. Wiedemann GJ. Weiss C. Kriz W, Schramm U. Robins HI. Pagel H. Whole-body hyperthermia combined with ifosfamide and carboplatin causes hypotension and nephrotoxicity. J Cancer Res Clin Oncol 1998; 124: 549-54.
  • [Line 1299]Gruber Y. Hegewisch-Becker S. Bakshandeh-Bath A. Sommer H. Hoffmann R. Hossfeld DK. Whole-body hyperthermia at 41.8 C combined with ifosfamide and carhoplatin in relapsed ovarian carcinoma pretreated with a platin-containing regimen, Ann Oncol 2000; 11(Suppl 4): 86.
  • [Line 1331]Page RL, Meyer RE. Thrall DE. Dewhirst MW. Cardiovascular and metabolic response of tumour-bearing dogs to whole body hypertliermia Int J Hyperthermia 1987: 3: 513-25.
  • [Line 1362]Pereira Arias AM. Wester JPJ. Blankendaal M. Schilthuis MS. Kuijper EJ. Rademaker BMP. Stoutenbeek CP. Rierbroek RC. Multiple organ dysfunction syndrome induced by whole-body hyperthermia and polychemotherapy in a patient with disseminated leiomyosarcoma of the uterus, Intensive Care Med 1999; 25: 1013-6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.